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Evaluation of mesenteric changes with elastosonography
and diffusion-weighted magnetic resonance imaging in
patients with Crohn's Disease: preliminary results.
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Aims and objectives
Magnetic resonance enterography (MRE) provides information in the study of Crohn's
disease (CD) and requires gadolinium injection. Through the MR images it is possible to
identify the main features of the disease such as the involvement of the bowel wall, and
the involvement of the near structures, especially the mesentery [1-7]. In particular, MRE
allows the hypertense signal of mesentery in the case of inflammation or hypointense in
the case of fibrosis.
Even the elastography (USE) maybe can distinguish the change of fibrotic and
edematous mesentery of patients with (CD).
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The aim of this study is focused to evaluate the diagnostic performance of USE and the
apparent diffusion coefficient (ADC) in differentiating fibrotic and oedematous change of
mesentery of patients with CD.
Methods and materials
Twenty-one patients (12 male and 9 female) with mean age of 31,22 ± 8,44 with Crohn
disease underwent magnetic resonance enterography and in the same time a real-time
USE from July 2014 to August 2015, in our Department. All patients have a histological
diagnosis of Crohn disease.
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The MR studies had been performed on two 1.5 Tesla superconducting device (Philips
Medical Systems, Shelton, CT). Patients fasted for 6 h before the MRI examination.
MR studies were realized with BBFEM2D sequence on the axial plane, T2 SPIR on
axial and coronal planes, E-THRIVE before and after contrast medium injection (after
30-75-120 sec) on axial and coronal planes and DWI sequences on the axial plane.
ADC values were calculated in the wall of terminal and normal ileum at b 500 and 800.
ADC values were calculated in the mesentery of pathological ileum (study group) and of
normal ileum (control group) selecting simultaneously images at b 0, 500 and 800 and
were compared with the USE colour-images in the same location. These results were
statistically analysed.
Results
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In our experience there was a significant (p<0,05) restriction of the diffusion in 13 patients
with CD in the active phase, in particular the mean ADC values for the fibrotic mesentery
2,80 ± 0,33 x 10-3, while the mean ADC values for oedematous mesentery: 2,20 ± 0,41
x 10-3.
In the study group, the USE colour-scale coding showed a colour change from blue to red
in the fibrotic change of mesentery (see Figure 2-3), and blue-green in the oedematous
change (see Figure 3), 8 and 13 patients respectively.
However, the difference between the control and the study group was still significant in
our study.
Images for this section:
Fig. 1: Fibrotic change of mesentery.
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Fig. 2: Fibrotic change of mesentery.
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Fig. 3: Edematous change of mesentery.
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Conclusion
Our results indicate that fibrotic and oedematous change of mesentery of patients with CD
cause restricted diffusion and that DWI yields both qualitative (increased signal intensity)
and quantitative (decreased ADC values) information that can be helpful in the evaluation
of mesentery. USE also confirmed the nonsolid nature of the mesenteric mass because
the tumor appeared almost entirely green (soft) on hardness colorimetric scale.
Evaluation of CD through USE and DWI is a more and more growing field, and many
tools are available.
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